An internal standard for the quantification of eplerenone
Related Products
Unlabeled Version(s)
15616Eplerenone
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Eplerenone-d3

Item No. 31610

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
(7α,11α,17α)-9,11-epoxy-17-hydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic acid, γ-lactone, 7-methyl ester-d3
Synonyms
  • (+)-Eplerenone-d3
  • Epoxymexrenone-d3
Molecular Formula
C24H27D3O6
Formula Weight
417.5
Purity
≥99% deuterated forms (d1-d3)
Formulation
A solid
SMILES
O=C1CC[C@@]2(C)C(C[C@@H](C(OC([2H])([2H])[2H])=O)[C@]3([H])[C@]2(O4)[C@@]4([H])C[C@@]5(C)[C@@]3([H])CC[C@]56OC(CC6)=O)=C1
InChi Code
InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1/i3D3
InChi Key
JUKPWJGBANNWMW-QAFNHEJQSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    2.5 mg

    $835

    Add
    Product Description

    Eplerenone-d3 is intended for use as an internal standard for the quantification of eplerenone (Item No. 15616) by GC- or LC-MS. Eplerenone is a mineralocorticoid receptor antagonist.1 It is selective for the mineralocorticoid receptor over glucocorticoid, androgen, progesterone, and estrogen receptors in radioligand binding assays (IC50s = 138, 6,920, 523, >10,000, and 5,702 nM, respectively). Eplerenone inhibits aldosterone-induced mineralocorticoid activity in a luciferase assay (IC50 = 122 nM). In vivo, eplerenone (100 mg/kg per day) reduces urinary albumin secretion and glomerulosclerosis in the Dahl salt-sensitive rat model of hypertension and nephropathy. It reduces myocardial IL-1β levels and collagen deposition, as well as improves left ventricular systolic dysfunction in a mouse model of acute myocardial infarction.2 Formulations containing eplerenone have been used in the treatment of hypertension and heart failure after myocardial infarction.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Meyers, M.J., Arhancet, G.B., Hockerman, S.L., et al. Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy. J. Med. Chem. 53(16), 5979-6002 (2010).

    2. Chen, B., Geng, J., Gao, S.-X., et al. Eplerenone modulates interleukin-33/sST2 signaling and IL-1β in left ventricular systolic dysfunction after acute myocardial infarction. J. Interferon. Cytokine Res. 38(3), 137-144 (2018).